EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Harnessing Particle Ions for FLASH Radiotherapy

Alex J Bembridge iD, Jonathan R Hughes iD, Jason L Parsons iD

Cells · 2026

DOI: 10.3390/cells15191729 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2026. Verfasst von Alex J Bembridge und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Hauptthemen laut MEDLINE: Neoplasms, Heavy Ion Radiotherapy, Ions, Radiotherapy. Die Arbeit nennt 96 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NCI NIH HHS, NIH Common Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

FLASH radiotherapy continues to be an emerging clinical treatment that utilises ultra-high dose rate radiation (>40 Gy/s) to elicit normal tissue sparing compared to conventional (CONV) dose rate delivery. This is termed the FLASH effect, which has also been demonstrated to lead to effective tumour control. FLASH sparing has been demonstrated in many studies using electrons and now increasingly with particle ions, particularly protons. Due to unique properties such as deeper penetrance and a narrow range of energy deposition providing more precision targeting, this makes hadron radiotherapy using FLASH an exciting innovation for cancer treatment to help improve outcomes for cancer patients. Furthermore, through the use of higher linear energy transfer (LET) particles such as helium and carbon ions, FLASH offers the potential to combine sparing of normal tissues with enhanced biological effectiveness in tumour cell killing, important for tumours that are more resistant to conventional photon radiotherapy. However, the physical and biological parameters by which the FLASH sparing effect occurs is complex and has not been fully characterised. Factors including total dose, pulse structure (dose and duration), beam energy and LET have all been reported to impact tissue sparing. Additionally, the underlying biological mechanism of action of FLASH remains a point of contention within the field. In this review, we provide an up-to-date report on FLASH studies conducted with particle ion therapies, including in vitro and in vivo studies, using different experimental models. We present both the cellular and molecular outcomes of the studies performed using protons, helium and carbon ions, plus other ion sources, and the accumulating evidence that demonstrate the strong clinical potential for these modalities in cancer treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsHeavy Ion RadiotherapyIonsRadiotherapyHumansAnimalsHeliumLinear Energy Transfer

Stichwörter der Autor:innen

FLASHcarbon ionshelium ionsionising radiationproton beam therapyradiotherapy

Substanzen

HeliumIons

Autor:innen und Institutionen

  • Department of Cancer and Genomic Sciences, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.
  • School of Physics and Astronomy, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK.

ORCID-Profile: Alex J Bembridge, Jonathan R Hughes, Jason L Parsons

Förderung

  • NCI NIH HHS
  • NIH Common Fund

Zitieren

APA

Bembridge, A. J., Hughes, J. R., & Parsons, J. L. (2026). Harnessing Particle Ions for FLASH Radiotherapy. Cells. https://doi.org/10.3390/cells15191729

Vancouver

Bembridge AJ, Hughes JR, Parsons JL. Harnessing Particle Ions for FLASH Radiotherapy. Cells. 2026. doi:10.3390/cells15191729

BibTeX
@article{Bembridge2026,
  author = {Bembridge, Alex J and Hughes, Jonathan R and Parsons, Jason L},
  title = {Harnessing Particle Ions for FLASH Radiotherapy},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15191729}
}
Kostenlos starten →